Last reviewed · How we verify

NCT07254442

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Completed Last updated 28 November 2025
What this trial tests

trial testing Hearing tests in Hearing in 90 participants. Completed in 1 March 2022.

Timeline
1 December 2021
Primary endpoint
1 February 2022
1 March 2022

Quick facts

Lead sponsorZonguldak Bulent Ecevit University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 December 2021
Primary completion1 February 2022
Estimated completion1 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Zonguldak Bulent Ecevit University

Who can join

Adults 18 to 35, any sex, with Hearing or COVID - 19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing

Currently open trials in the same condition.

Other Zonguldak Bulent Ecevit University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07254442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing